Billal Tedbirt
Inserm(FR)Normandie Université(FR)Université de Rouen Normandie(FR)
Publications by Year
Research Areas
Autoimmune Bullous Skin Diseases, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Urticaria and Related Conditions, Cutaneous lymphoproliferative disorders research, Platelet Disorders and Treatments
Most-Cited Works
- → UpdatedS2K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)(2022)229 cited
- → Mixed Individual-Aggregate Data on All-Cause Mortality in Bullous Pemphigoid(2021)25 cited
- → Comparison of real costs in the French healthcare system in newly diagnosed patients with pemphigus for first‐line treatment with rituximab vs. standard corticosteroid regimen: data from a national multicentre trial(2019)20 cited
- → Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study(2024)19 cited
- → Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy(2024)19 cited
- → Rechallenge of immune checkpoint inhibitor after pembrolizumab-induced myasthenia gravis(2019)18 cited
- → Clinical Features, Histological Characteristics, and Disease Outcomes of Mycosis Fungoides in Children and Adolescents: A Nationwide Multicentre Cohort of 46 Patients(2022)9 cited
- → Severe acute generalized exanthematous pustulosis (AGEP) induced by miconazole oral gel with overlapping features of drug reaction with eosinophilia and systemic symptoms (DRESS)(2020)9 cited
- → How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International Survey(2022)7 cited
- → Reactive Eccrine Syringofibroadenomatosis Associated With Venous Leg Ulcers: A Case Report and Literature Review(2020)6 cited